A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients.
about
Medication Related Osteonecrosis of the Jaw: 2015 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial SurgeonsDental complications and management of patients on bisphosphonate therapy: A review articleNew dimensional staging of bisphosphonate-related osteonecrosis of the jaw allowing a guided surgical treatment protocol: long-term follow-up of 266 lesions in neoplastic and osteoporotic patients from the university of bari.Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patientsA SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancer.Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw.Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer.Pathophysiology of Osteonecrosis of the Jaws.Ninety-one osteoporosis patients affected with bisphosphonate-related osteonecrosis of the jaw: a case series.Treatment of bisphosphonate related osteonecrosis following root canal therapy at the 1-year follow-up: report of two cases.Zoledronic acid: an unending tale for an antiresorptive agent.Bisphophonates related osteonecrosis of the jawEpidemiology and risk factors for osteonecrosis of the jaw in cancer patients.The impact of bisphosphonates on oral health: lessons from the past and opportunities for the future.A review of the clinical implications of bisphosphonates in dentistry.Review of new guidelines for the management of glucocorticoid induced osteoporosis.Response to comments on "diagnosis and management of osteoporosis of the jaw: a systematic review and international consensus".Periodontal Disease, Dental Implants, Extractions and Medications Related to Osteonecrosis of the Jaws.Genetic and acquired factors influencing the effectiveness and toxicity of drug therapy in osteoporosis.Resection and microvascular reconstruction of bisphosphonate-related osteonecrosis of the jaw: The role of microvascular reconstruction.Prevalence of Food Impaction-Induced Periodontitis in Conventionally Housed Marsh Rice Rats (Oryzomys palustris).Incidence of bisphosphonate-related osteonecrosis of the jaws (BRONJ) in patients taking bisphosphonates for osteoporosis treatment - a grossly underestimated risk?Concomitant factors leading to an atypical osteonecrosis of the jaw in a patient with multiple myeloma.Incidence and risk factors of bisphosphonate-related osteonecrosis of the jaw in multiple myeloma patients having undergone autologous stem cell transplantation.Does dental and oral health influence the development and course of bisphosphonate-related osteonecrosis of the jaws (BRONJ)?A study of 225 patients on bisphosphonates presenting to the bisphosphonate clinic at King's College Hospital.Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid.A Case of Osteonecrosis of the Jaw in a Patient with Crohn's Disease Treated with Infliximab.Bisphosphonate guidelines for treatment and prevention of myeloma bone disease.Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases.Prevalence of Medication-Related Osteonecrosis of the Jaw in Patients with Breast Cancer, Prostate Cancer, and Multiple Myeloma.Legal liability in bisphosphonate-related osteonecrosis of the jaw
P2860
Q26771715-EFFD9764-601B-410B-8C14-BB0115B088F6Q27022492-AB24023F-E11B-4A50-B3FA-59EAE54BA76BQ33796816-807A3129-A4FB-4C64-B8CB-996393DC97BEQ34031441-01B64A11-4A4B-440D-BC5F-B26DEAE8EBB6Q34392792-CFBA466E-702A-40FF-9D23-81BE3ECDFD18Q35584343-0EB8CB8F-77DA-4CF1-A685-5346A3D8E806Q36553506-C708F937-F1A7-410F-9951-9EE91DD61030Q37006852-F85FEE59-ABEA-4B61-8F7B-68E842EC0541Q37097852-A3A4B0B5-BC09-452A-962F-C5C63976C5A4Q37388377-E481B120-D3F9-40D5-A24E-52694BBCAADFQ37650334-760F3D9E-A7D0-4854-981E-EFEA58AEA913Q37654069-6F6DD99A-65D4-43B2-9D89-72DC43C1B168Q37800176-0A4BA51E-7131-4DDF-BC55-E694106DDA12Q37835357-714BE8BC-59BC-4D17-9025-4F5E0F321617Q37844656-16C17D35-49A6-4574-9CE2-DBA5B0B679C3Q38151513-5363DA5E-52C9-401D-BD9C-F6A3C33C55DBQ38457969-9B1A823E-4252-4606-96CC-686D55EDF80BQ38691628-4178BA11-9943-492D-A476-C226956C400FQ38739527-55FF6E4C-5E02-4E27-B4E3-64B5DB4C13AFQ38829698-EC7548ED-F0DB-4038-A7AF-5C2B5D77D425Q38949673-0B2FD048-AC93-46DC-B600-FF3E034E538FQ39527504-50577B55-C691-425B-B3FD-51529F880F84Q41866891-0BFBFB2D-E722-45D7-AA55-681496F85108Q44042571-C4C21494-7B00-44CE-808A-39A16942CC34Q44084934-91895006-08D7-49FC-AD08-A3B0C9832FAFQ44694871-52345EA7-5637-444A-A186-E8BD519EE338Q46438797-30127D84-B435-488F-A5FE-2BA873F942E2Q47120536-7B35B002-671C-4521-96CE-9FA73010927BQ48283228-F5D31854-65FC-4C6B-A25A-D6CC9D00807CQ51522929-C1163433-C8D6-40D0-B129-004376413963Q55384058-E3136B73-25B3-4493-8123-2D0B1022B6C0Q57764774-7F781FF2-5258-4227-B525-B741DCAFFE37
P2860
A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
A retrospective study assessin ...... in multiple myeloma patients.
@en
type
label
A retrospective study assessin ...... in multiple myeloma patients.
@en
prefLabel
A retrospective study assessin ...... in multiple myeloma patients.
@en
P2093
P356
P1433
P1476
A retrospective study assessin ...... in multiple myeloma patients.
@en
P2093
P304
P356
10.1093/ANNONC/MDM370
P577
2007-09-05T00:00:00Z